The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy

Diabetologia

Volumn 41, Issue 3, 1998, Pages 330-336

  Jude, E B ^a   Abbott, C A ^a   Young, M J ^a   Anderson, S G ^b   Douglas, J T ^a   Boulton, A J M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cell adhesion molecules; Diabetes mellitus; Diabetic peripheral neuropathy; Haemostatic factors; Nerve conduction velocity

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HUMAN; NERVE CONDUCTION; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL ADHESION MOLECULES; DIABETIC NEUROPATHIES; HUMANS; HYPERGLYCEMIA; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; NEURAL CONDUCTION; P-SELECTIN; PERIPHERAL NERVOUS SYSTEM; PROSPECTIVE STUDIES; REFERENCE VALUES; REGRESSION ANALYSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031780580     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050911     Document Type: Article

References (34)

1. Young MJ, Boulton AJM, McLeod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic neuropathy in the UK hospital clinic population. Diabetologia 36: 150-154
2. Tesfaye S, Stevens LK, Stephenson JM et al. (1996) The prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the Eurodiab IDDM complications study. Diabetologia 39: 1377-1384
3. Dyck PJ, Kratz KM, Karnes JL et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 43: 817-824
4. Lee BC, Tooke JE (1997) An overview of diabetic complications. In: Boulton AJM (ed) Diabetic neuropathy. Marius Press, Lancashire, UK, pp 21-39
5. Cotter MA, Cameron NE (1997) The aetiopathogenesis of diabetic neuropathy; Metabolic theories and vascular theories. In: Boulton AJM (ed) Diabetic neuropathy. Marius Press, Lancashire, UK, pp 97-146
6. Tesfaye S, Malik RA, Ward JD (1994) Vascular factors in diabetic neuropathy. Diabetologia 37: 847-853
7. Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92-102
8. Dyck PJ, Hansen S, Karnes J et al. (1985) Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82: 2513-2517
9. Timperley WR, Boulton AJM, Davies-Jones GA, Jarrett JA, Ward JD (1985) Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol 38: 1030-1038
10. Fasching P, Waldhausl W, Wagner OF (1996) Elevated circulating adhesion molecules in NIDDM - potential mediators in diabetic macroangiopathy. Diabetologia 39: 1242-1244
11. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD (1994) Increased levels of soluble adhesion molecules are independent of glycaemic control. Thromb Haemost 72: 979-984
12. Cominacini L, Pasini AF, Garbin U et al. (1995) Elevated levels of soluble E- selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38: 1122-1124
13. Jilma B, Fasching P, Ruthner C et al. (1996) Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thrombosis Haemostasis 76: 328-332
14. Fasching P, Veitl M, Rohac M, et al. (1996) Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 4313-4317
15. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E (1996) Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92: 747-750
16. Ford I, Malik RA, Newrick PG, Preston FE, Ward JD (1992) Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68: 628-633
17. Young MJ, Jones GC (1997) Diabetic neuropathy: symptoms, signs and assessment. In: Boulton AJM (ed) Diabetic neuropathy. Marius Press, Lancashire, UK, pp 41-62
18. Blackburn H, Keys A, Simonsen E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies: a classification system. Circulation 21: 1160-1175
19. Veves A, Malik RA, Masson EA, Sharma AK, Schady W, Boulton AJM (1991) The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabetic Med 8: 917-921
20. Ziegler D, Mayer P, Muhlen H, Greis FA (1991) The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 822-829
21. Boulton AJM, Hardisty CA, Betts RB et al. (1983) Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6: 26-33
22. Young RJ, Zhou YQ, Rodriquez E et al. (1986) Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 35: 192-197
23. McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147: 642-665
24. Gearing AJH, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14: 506-512
25. Faruqi RM, DiCorleto PE (1993) Mechanisms of monocyte recruitment and accumulation. Br Heart J 69[Suppl]:S19-S29
26. Yamada K, Naoko T, Otabe S, Inada C, Inoue M, Nonaka K (1993) Pancreatic β-cell-selective production of tumour necrosis factor-α induced by interleukin-1. Diabetes 42: 1026-1031
27. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMJ 293: 1053-1054
28. Poston RN, Dorian OH, Coucher JR, Nichola PG, Johnson-Tidey RR (1994) Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140: 665-673
29. Lorenzi M, Cagliero E (1991) Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 40: 653-659
30. Poston L, Taylor PD (1995) Endothelium-mediated vascular function in insulin-mediated diabetes mellitus. Clin Sci 88: 245-255
31. Young MJ, Bennett JL, Liderth SA, Veves A, Douglas JT, Boulton AJM (1996) Rheological and microvascular parameters in diabetic peripheral neuropathy. Clin Sci 90: 183-187
32. Walker JD, Viberti GC (1991) Pathophysiology of microvascular disease: an overview. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Scientific Publications, Oxford, pp 526-533
33. Plater ME, Ford I, Dent MT, Preston FE, Ward JD (1996) Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function. Diabetologia 39: 336-343
34. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986